Gerald Kane
@Nordwand Advisors, Llc
Latest period2024 - Q3ReportedManaged Assets$373.635MTotal holdings141
Assets growth rate62.97%Assets growth rate (2-Q avg)26.04%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Nordwand Advisors, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 141 positions.
Assets under management
The assets under management (AUM) of Nordwand Advisors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 373.635M in assets, with a quarterly growth rate of 62.97% and a 2-quarter average growth rate of 26.04%. The portfolio is managed by Gerald Kane, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
OSEAHarbor Etf Trust
| 1.16% | $4.313M 149,085 shares@ $28.93 avg price | New Position |
TECXTectonic Therapeutic Inc
| 0.02% | $45,450 1,500 shares@ $30.3 avg price | New Position |
MUMicron Technology Inc
| 0.01% | $20,742 200 shares@ $103.71 avg price | New Position |
CAVACava Group Inc
| 0.01% | $12,385 100 shares@ $123.85 avg price | New Position |
GROVGrove Collaborative Hold Inc
| 0.01% | $4,050 3,000 shares@ $1.35 avg price | New Position |
MURAMural Oncology Pub Ltd Co
| 0.01% | $3,130 1,000 shares@ $3.13 avg price | New Position |
RETOReto Eco Solutions Inc
| 0.01% | $3,020 2,000 shares@ $1.51 avg price | New Position |
AIFUFanhua Inc
| 0.01% | $2,840 2,000 shares@ $1.42 avg price | New Position |
ORMPOramed Pharmaceuticals Inc
| 0.01% | $2,440 1,000 shares@ $2.44 avg price | New Position |
USIOUsio Inc
| 0.01% | $2,040 1,500 shares@ $1.36 avg price | New Position |